Cortiment: first budesonide tablet for ulcerative colitis

Cortiment is taken as a single tablet once daily for up to 8 weeks.
Cortiment is taken as a single tablet once daily for up to 8 weeks.

Cortiment (budesonide) 9mg prolonged-release tablets are now available from Ferring, for the induction of remission in mild to moderate active ulcerative colitis where mesalazine is not sufficient. A single tablet is taken once daily for up to 8 weeks.

In the CORE I study in 509 patients with active mild to moderate ulcerative colitis, 2.4 times more patients achieved clinical remission with the prolonged-release budesonide tablets than with placebo (17.9% vs 12.1%, p=0.0143) and rates of adverse events were similar.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases